ProQR Therapeutics (PRQR) Cash & Equivalents (2013 - 2026)
ProQR Therapeutics' Cash & Equivalents was $136.14 million in the quarter ended Jun 30, 2026, up 0.4% from $135.57 million a year earlier and up 43.4% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Cash & Equivalents (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at ProQR Therapeutics came in at $104.41 million, down 35.4% from the prior year.
- Cash & Equivalents shows a five-year compound annual growth rate of 3.8% (years ended Dec 2020 to Dec 2025).
- In earlier years, Cash & Equivalents was $161.71 million in the year ended Dec 31, 2024 (+24.6%), $129.81 million in the year ended Dec 31, 2023 (+30.0%), $99.89 million in the year ended Dec 31, 2022 (-99.9%) and $89.75 billion in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Cash & Equivalents since the quarter ended Mar 31, 2025.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 9.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was the quarter ended Dec 31, 2021 (growth of 137.2%); the worst was the quarter ended Dec 31, 2022 (a decline of 54.9%).
- Per Business Quant data, PRQR's Cash & Equivalents in the three quarters before the quarter ended Jun 30, 2026 was $94.93 million (quarter ended Mar 31, 2026), $107.57 million (quarter ended Dec 31, 2025) and $124.95 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | ProQR Therapeutics | 171.74 Mn | -291.86 Mn | - | 136.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.14 Mn |
| Mar 31, 2026 | 94.93 Mn |
| Dec 31, 2025 | 107.57 Mn |
| Sep 30, 2025 | 124.95 Mn |
| Jun 30, 2025 | 135.57 Mn |
| Mar 31, 2025 | 139.28 Mn |
| Dec 31, 2024 | 159.66 Mn |
| Sep 30, 2024 | 98.18 Mn |
| Jun 30, 2024 | 85.04 Mn |
| Mar 31, 2024 | 93.12 Mn |
| Dec 31, 2023 | 127.96 Mn |
| Sep 30, 2023 | 131.23 Mn |
| Jun 30, 2023 | 139.99 Mn |
| Mar 31, 2023 | 149.18 Mn |
| Dec 31, 2022 | 96.69 Mn |
| Sep 30, 2022 | 101.26 Mn |
| Jun 30, 2022 | 166.89 Mn |
| Mar 31, 2022 | 188.12 Mn |
| Dec 31, 2021 | 214.52 Mn |
| Sep 30, 2021 | 184.14 Mn |
API Access
ProQR Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();